Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saif Huda

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Neurology|November 19, 2024
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSDPakeeran Siriratnam, Saif Huda, Anneke Van Der Walt, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 4, 2024
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre studyPakeeran Siriratnam, Paul Sanfilippo, Anneke van der Walt, et al.
JAMA Neurology|April 4, 2022
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseJohn J Chen, Saif Huda, Yael Hacohen, et al.
Neurology|March 5, 2026
Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum DisorderPakeeran Siriratnam, Vilija G Jokubaitis, Anneke Van Der Walt, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 16, 2026
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum DisorderJoao Vitor Mahler, Gerome B Vallejos, Takahisa Mikami, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 4, 2026
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum DisorderJoao Vitor Mahler, Gerome B Vallejos, Takahisa Mikami, et al.
Annals of Clinical and Translational Neurology|November 17, 2025
Lessons Learned: Quality Analysis of Optical Coherence Tomography in Neuromyelitis OpticaHadi Salih, Sara Samadzadeh, Charlotte Bereuter, et al.
American Journal of Ophthalmology|February 23, 2023
Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis AttacksJohn J Chen, Eoin P Flanagan, Sean J Pittock, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 22, 2023
Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disordersFrederike Cosima Oertel, Hanna G Zimmermann, Seyedamirhosein Motamedi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2024
Employment, work hours, and wages in adults with myelin oligodendrocyte glycoprotein antibody disease: An international cohort studyAndrew Siyoon Ham, Isabella Gomez Hjerthen, Akshatha Sudhir, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Neurology|November 19, 2024
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSDPakeeran Siriratnam, Saif Huda, Anneke Van Der Walt, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 4, 2024
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre studyPakeeran Siriratnam, Paul Sanfilippo, Anneke van der Walt, et al.
JAMA Neurology|April 4, 2022
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseJohn J Chen, Saif Huda, Yael Hacohen, et al.
Neurology|March 5, 2026
Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum DisorderPakeeran Siriratnam, Vilija G Jokubaitis, Anneke Van Der Walt, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 16, 2026
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum DisorderJoao Vitor Mahler, Gerome B Vallejos, Takahisa Mikami, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 4, 2026
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum DisorderJoao Vitor Mahler, Gerome B Vallejos, Takahisa Mikami, et al.
Annals of Clinical and Translational Neurology|November 17, 2025
Lessons Learned: Quality Analysis of Optical Coherence Tomography in Neuromyelitis OpticaHadi Salih, Sara Samadzadeh, Charlotte Bereuter, et al.
American Journal of Ophthalmology|February 23, 2023
Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis AttacksJohn J Chen, Eoin P Flanagan, Sean J Pittock, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 22, 2023
Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disordersFrederike Cosima Oertel, Hanna G Zimmermann, Seyedamirhosein Motamedi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2024
Employment, work hours, and wages in adults with myelin oligodendrocyte glycoprotein antibody disease: An international cohort studyAndrew Siyoon Ham, Isabella Gomez Hjerthen, Akshatha Sudhir, et al.
Pageof 8